UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

The influence of deprivation in the outcomes of psoriatic arthritis within the UK-utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data

Rheumatology advances in practice, 2024, Vol.8 (2), p.rkae051

2024

Volltextzugriff (PDF)

Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response

Rheumatology advances in practice, 2024, Vol.8 (1), p.rkae014-rkae014

2024

Volltextzugriff (PDF)

Comment on: Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement

Rheumatology (Oxford, England), 2018-02, Vol.57 (2), p.401-402

Tillett, William

2018

Volltextzugriff (PDF)

Diagnosis, classification, and assessment in psoriatic arthritis

Best practice & research. Clinical rheumatology, 2021-06, Vol.35 (2), p.101669-101669, Article 101669

2021

Volltextzugriff (PDF)

Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial

Arthritis research & therapy, 2023-09, Vol.25 (1), p.1-169, Article 169

2023

Volltextzugriff (PDF)

Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis

Arthritis research & therapy, 2024-02, Vol.26 (1), p.50-15, Article 50

2024

Volltextzugriff (PDF)

Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.714-720

2020

Volltextzugriff (PDF)

Work disability in psoriatic arthritis: a systematic review

Rheumatology (Oxford, England), 2012-02, Vol.51 (2), p.275-283

2012

Volltextzugriff (PDF)

Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis

Rheumatology (Oxford, England), 2022-02, Vol.61 (2), p.581-590

2022

Volltextzugriff (PDF)

The evolving demographics of participants in psoriatic arthritis phase III randomised controlled trials of b/tsDMARDs: A systematic review

Seminars in arthritis and rheumatism, 2023-06, Vol.60, p.152175-152175, Article 152175

2023

Volltextzugriff (PDF)

Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis

Annals of the rheumatic diseases, 2013-08, Vol.72 (8), p.1358-1361

2013

Volltextzugriff (PDF)

Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study

Rheumatic & musculoskeletal diseases open, 2023-01, Vol.9 (1), p.e002533

2023

Volltextzugriff (PDF)

Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study

Clinical and experimental rheumatology, 2023-11, Vol.41 (11), p.2286

2023

Volltextzugriff (PDF)

e60 A critical literature review of the effectiveness and safety of dietary interventions for the treatment of psoriasis and psoriatic arthritis

Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3)

2018

Volltextzugriff (PDF)

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study

Journal of rheumatology, 2012-01, Vol.39 (1), p.154

2012

Volltextzugriff (PDF)

Psoriatic arthritis

Nature reviews. Disease primers, 2021-08, Vol.7 (1), p.59-59, Article 59

2021

Volltextzugriff (PDF)

Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study

Rheumatology (Oxford, England), 2015-01, Vol.54 (1), p.157-162

2015

Volltextzugriff (PDF)

Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice

Annals of the rheumatic diseases, 2018-03, Vol.77 (3), p.343

2018

Volltextzugriff (PDF)

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

Annals of the rheumatic diseases, 2017-04, Vol.76 (4), p.673

2017

Volltextzugriff (PDF)

A study of obesity, BMI, smoking and alcohol as risk factors for psoriatic arthritis

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.e97-e97

2020

Volltextzugriff (PDF)

Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight‐Control Clinical Trial and an Observational Cohort

Arthritis care & research (2010), 2018-08, Vol.70 (8), p.1198-1205

2018

Volltextzugriff (PDF)

A qualitative study of patients’ experiences of screening for psoriatic arthritis

British journal of dermatology (1951), 2022-12, Vol.187 (6), p.1035-1037

2022

Volltextzugriff (PDF)

Impact of Physician-Defined Flares on Quality of Life and Work Impairment: An International Survey of 2238 Patients With Psoriatic Arthritis

Journal of rheumatology, 2023-01, Vol.50 (1), p.76

2023

Volltextzugriff (PDF)

Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort

Frontiers in medicine, 2023-06, Vol.10, p.1184028-1184028

2023

Volltextzugriff (PDF)

Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE

Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.617-628

2023

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAudio

SpracheSlowenisch

ThemaPsoriatic Arthritis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(78)
Buchkapitel
(1)

Sprache

Englisch
(79)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(69)
Science & Technology
(69)
Rheumatology
(67)
Humans
(51)
Psoriasis
(36)
Arthritis, Psoriatic - Drug Therapy
(25)
Arthritis, Psoriatic - Diagnosis
(23)
Female
(22)
Quality Of Life
(21)
Severity Of Illness Index
(21)
Male
(20)
Patients
(19)
Arthritis
(17)
Middle Aged
(16)
Adult
(15)
Medicine
(15)
Treatment Outcome
(15)
Antirheumatic Agents - Therapeutic Use
(14)
Medicine & Public Health
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The influence of deprivation in the outcomes of psoriatic arthritis within the UK-utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data

Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response

Comment on: Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement

Diagnosis, classification, and assessment in psoriatic arthritis

Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial

Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis

Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis

Work disability in psoriatic arthritis: a systematic review

Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis

The evolving demographics of participants in psoriatic arthritis phase III randomised controlled trials of b/tsDMARDs: A systematic review

Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis

Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study

Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study

e60 A critical literature review of the effectiveness and safety of dietary interventions for the treatment of psoriasis and psoriatic arthritis

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study

Psoriatic arthritis

Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study

Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

A study of obesity, BMI, smoking and alcohol as risk factors for psoriatic arthritis

Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight‐Control Clinical Trial and an Observational Cohort

A qualitative study of patients’ experiences of screening for psoriatic arthritis

Impact of Physician-Defined Flares on Quality of Life and Work Impairment: An International Survey of 2238 Patients With Psoriatic Arthritis

Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort

Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE

Aktive Filter

Suchergebnisse filtern